BSFABSF Enterprise Plc
1.300GBP+10.64%Mkt Cap: 3.23M $P/E:

BSF Enterprise Plc, together with its subsidiaries, develops and commercializes cell-based tissue engineering solutions in the United Kingdom and Hong Kong. The company acquires businesses in the biotechnology, marketing…

Key Statistics

Company
Market Cap3.23M $
Enterprise Value3.07M $
Revenue (TTM)65.50K $
Gross Profit-23.29K $
Net Income (TTM)-1.43M $
Revenue/Share0.0000 USD
Last Price1.300 GBP
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees14
CountryGB
SectorFinancial Services
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)
PEG
EV/EBITDA-1.74
EV/Revenue46.82
P/S58.81
P/B1.11
EPS (TTM)-0.01
EPS (Forward)
52W Range
0.000032% of range4.000
52W High4.000 GBP
52W Low0.0000 GBP
Profitability
Gross Margin-34.37%
Oper. Margin-5382.97%
EBITDA Margin0.00%
Profit Margin-2107.36%
ROE-40.97%
ROA-37.03%
Growth
Revenue Growth-8.60%
Earnings Growth
Cash Flow & Leverage
Operating CF-1.29M $
CapEx (TTM)13.28K $
FCF Margin-439.92%
FCF Yield-8.92%
Net Debt926.23K $
Net Debt/EBITDA-0.53
Balance Sheet
Debt/Equity0.00
Current Ratio0.33
Quick Ratio0.24
Book Value/Sh0.0140 GBP
Cash/Share0.0000 GBP
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 GBP
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:12
Split DateFeb 27, 2026
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.193.75M
Float95.78M
Insiders19.68%
Institutions0.02%
Technical
SMA 501.010 (+28.6%)
SMA 2001.639 (-20.7%)
Beta3.61
S&P 52W Chg18.16%
Avg Vol (30d)2.87M
Avg Vol (10d)4.09M
Technical Indicators
RSI (14)61.5
MACD0.0327
MACD Signal-0.0221
MACD Hist.+0.0548
BB Upper1.320 GBP
BB Middle0.9855 GBP
BB Lower0.6513 GBP
BB Width67.83%
ATR (14)0.3029 GBP
Vol Ratio (20d)2.44x